In our study, we determined the gene mutation profile of ctDNA using CAPP-Seq, not only in gynecological cancer, but also in metastasis from colorectal cancer to the ovary, which exhibited the well-known genetic signature of colorectal cancer (KRAS, APC, and TP53 mutations and a MET copy-number gain). This evidence concerns the gene KRAS and female reproductive organ cancer.